Drug Detail

Information about KW-2450

Generic Name
IND	KW-2450
Brand Name (US)
Manufacturer	Kirin
Drug Type
Delivery	Oral
Approval Status	Phase 1
Indications
Overall Strategy	GIST cell based
Strategy	Block related tumor signal paths
Drug Category	IGF1R inhibitor

KW-2450 inhibits the insulin receptor pathway and the insulin-like growth factor receptor pathway, which have increased activity in some forms of cancer.